| Date | Time | Source | Headline | Symbol | Company |
| 08/07/2023 | 12:01PM | UK Regulatory | MaxCyte, Inc. Total Voting Rights and Block Listing Return | LSE:MXCT | Maxcyte Inc |
| 08/01/2023 | 9:26AM | Alliance News |  TRADING UPDATES: MaxCyte strikes deal; Barkby sells Workshop | LSE:MXCT | Maxcyte Inc |
| 08/01/2023 | 8:05AM | UK Regulatory | MaxCyte, Inc. Strategic Platform License with Prime Medicine | LSE:MXCT | Maxcyte Inc |
| 07/31/2023 | 12:26PM | UK Regulatory | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
| 07/26/2023 | 9:31AM | UK Regulatory | MaxCyte, Inc. TR-1: Notification of major holdings | LSE:MXCT | Maxcyte Inc |
| 07/24/2023 | 12:08PM | UK Regulatory | MaxCyte, Inc. TR-1: Notification of major holdings | LSE:MXCT | Maxcyte Inc |
| 07/24/2023 | 12:06PM | UK Regulatory | MaxCyte, Inc. TR-1: Notification of major holdings | LSE:MXCT | Maxcyte Inc |
| 07/13/2023 | 8:05AM | UK Regulatory | MaxCyte, Inc. Notice of Second Quarter 2023 Financial Results | LSE:MXCT | Maxcyte Inc |
| 07/11/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. TR-1: Notification of major holdings | LSE:MXCT | Maxcyte Inc |
| 07/10/2023 | 9:05AM | Alliance News | MaxCyte inks deal with Vittoria Therapeutics for cellular therapies | LSE:MXCT | Maxcyte Inc |
| 07/10/2023 | 8:05AM | UK Regulatory | MaxCyte, Inc. Signing of Strategic Platform License | LSE:MXCT | Maxcyte Inc |
| 07/10/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. TR-1: Notification of major holdings | LSE:MXCT | Maxcyte Inc |
| 07/07/2023 | 4:23AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 07/06/2023 | 11:41AM | UK Regulatory | MaxCyte, Inc. TR-1: Notification of major holdings | LSE:MXCT | Maxcyte Inc |
| 07/06/2023 | 8:58AM | Alliance News | MaxCyte inks strategic platform license with Lyell Immunopharma | LSE:MXCT | Maxcyte Inc |
| 07/06/2023 | 8:05AM | UK Regulatory | MaxCyte, Inc. Signing of Strategic Platform License | LSE:MXCT | Maxcyte Inc |
| 06/29/2023 | 10:19AM | UK Regulatory | MaxCyte, Inc. TR-1: Notification of major holdings | LSE:MXCT | Maxcyte Inc |
| 06/29/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. TR-1: Notification of major holdings | LSE:MXCT | Maxcyte Inc |
| 06/29/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
| 06/23/2023 | 10:46AM | UK Regulatory | MaxCyte, Inc. Grant of Options | LSE:MXCT | Maxcyte Inc |
| 06/23/2023 | 2:17AM | UK Regulatory | MaxCyte, Inc. Result of AGM | LSE:MXCT | Maxcyte Inc |
| 06/23/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. Result of AGM | LSE:MXCT | Maxcyte Inc |
| 06/21/2023 | 5:10AM | UK Regulatory | MaxCyte, Inc. Publication of Annual Report | LSE:MXCT | Maxcyte Inc |
| 06/16/2023 | 7:32AM | UK Regulatory | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
| 06/02/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. Upcoming Investor Conferences | LSE:MXCT | Maxcyte Inc |
| 06/01/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 05/11/2023 | 5:26AM | Alliance News | MaxCyte revenue declines, operating loss widens as costs increase | LSE:MXCT | Maxcyte Inc |
| 05/11/2023 | 2:22AM | UK Regulatory | MaxCyte, Inc. Filing of Form 10-Q | LSE:MXCT | Maxcyte Inc |
| 05/11/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. First Quarter Financial Results | LSE:MXCT | Maxcyte Inc |
| 05/10/2023 | 1:35AM | Alliance News | GET READY: Compass, Harbour Energy, JD Wetherspoon, TUI at 0700 BST | LSE:MXCT | Maxcyte Inc |